Drug Trial Radar · NCT06585241
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Last checked: Nov 20, 2026Latest source record: Mar 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,144
Planned (sponsor's estimate)
Start
Sep 9, 2024
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- ModernaTX, Inc.Moderna (MRNA)
- Sponsor type
- Industry
- First posted
- Sep 5, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the immunogenicity and safety of mRNA COVID-19 variant-containing vaccine formulations against the vaccine-matched variants and newly emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Conditions
- SARS-CoV-2
Interventions
mRNA-1273 Variant-containing FormulationBiological
Sterile liquid for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- mRNA-1273.167, mRNA-1273.712, mRNA-1273.251, and mRNA-1273.261: Geometric Mean Value of Neutralizing Antibody Against COVID-19 VariantsTime frame: Up to Day 29
- mRNA-1273.167, mRNA-1273.712, mRNA-1273.251, and mRNA-1273.261: Geometric Mean Fold Rise of Neutralizing Antibody Against COVID-19 VariantsTime frame: Up to 28 days after last dose of study intervention
- mRNA-1273.251 and mRNA-1273.261: Seroresponse RateTime frame: Up to Day 29
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
CenExel
Atlanta, Georgia · Recruiting
CenExel
Decatur, Georgia · Recruiting
Velocity Clinical Research
Baton Rouge, Louisiana · Recruiting
Velocity Clinical Research
Gulfport, Mississippi · Recruiting
Velocity Clinical Research
Omaha, Nebraska · Recruiting
Richard Bennett - Clinical Research Partners
Richmond, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.